Yüklüyor......
Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
BACKGROUND: Human epidermal growth factor receptor 2 (HER2)–positive breast cancer is highly aggressive and has higher risk of recurrence than HER2-negative cancer. With few treatment options available, new drug targets specific for HER2-positive breast cancer are needed. METHODS: We conducted a pha...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472971/ https://ncbi.nlm.nih.gov/pubmed/23042933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs396 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|